Prophylactic Use of Mepitel® Film to Prevent Radiation-Induced Moist Desquamation in Cancer Patients

Cancer patients had limited treatment options for decades, such as surgery, chemotherapy, and radiation therapy, alone or combined. However, there have been substantial improvements in recent years with the introduction of stem cell hormone anti-angiogenic treatments, immunotherapy, dendritic cell-based targeted ablation nanoparticles, natural antioxidants, radionics, chemodynamic sonodynamic ferroptosis-based therapy. Radiation radiotherapy, is a cancer that employs high doses to eliminate cells shrink tumors. This effective primary, adjuvant, palliative It an essential, efficient, cost-effective intervention crucial providing proper oncology care. Although modalities intensity-modulated radiotherapy advanced, they still risk harming skin surrounding healthy tissue. Radiotherapy may induce clinical toxicity leading chronic acute dermatitis, depending on caused by whether its form, can cause shedding result formation wounds. Such also lead non-healing ulcers radionecrosis. Mepitel® film helps control radiation-induced moist desquamation patients. Clinical trials prophylactic use Mepitel did not show similarities among from various countries; however, film-based method more beneficial than other methods. review examines types dressings utilized managing dermatitis enhance wound healing effectiveness while avoiding harm newly developing tissues. Additionally, this compares using treating